Forensic · DMAAU
Drugs Made In America Acquisition Corp.
No signals triggered in our 36-month window. Most stable large-caps look like this. The $9 report still gets you the full chronology of every filing scanned + a clean-record audit trail.
Bear case preview · free
Drugs Made In America Acquisition Corp. (DMAAU) returned a clean 36-month scan with no bankruptcy filings, financial restatements, exchange delistings, unexpected officer resignations, shareholder dilution events, or documented cyber breaches—the primary triggers in our algorithm's risk matrix. The entity's SEC filing cadence, insider transaction patterns, and regulatory correspondence showed no anomalies that would elevate flag thresholds. A score reset would require material adverse changes such as missed quarterly filings, insider trading investigations, merger deal collapse, or significant dilution announcements within the next 30-90 days.
↑ That's free. The $9 report goes deeper: every filing cited by accession number, 36-month chronology, what to watch next.
What we checked
✓ Red flags · 36mo
0 8-K events (bankruptcy, delisting, restatement, auditor, officer)
✓ Cyber · 12mo
0 Item 1.05 disclosures + buried-cyber scan
✓ Dilution · 24mo
0 S-3 + 424B5 filings
✓ Buried events
Item 8.01 sections classified for hidden material disclosures
$9
· one-time · emailed in under a minute
The full bear case on DMAAU
Plain-English brief. Every signal cited to the exact SEC filing. 36-month chronology. What changes next.
✓ No-signals refund: if the algorithm finds zero red flags on your ticker, reply "refund" and I send the $9 back same day. No questions.
Not ready to buy? Get a free preview by email instead
We'll email you the top 3 signals on DMAAU + a discount code for the full report. No subscription, no spam.
Score another ticker
Not investment advice. Every signal grounded in a specific SEC filing. Companies may respond via info@filingfirehose.com.